Draft Guidances Relating to the Development of Biosimilar Products; Public Hearing; Request for Comments

11 organizations filed 12 public comments on Draft Guidances Relating to the Development of Biosimilar Products; Public Hearing; Request for Comments, at the Food and Drug Administration. The comment window closed 5177d ago.

Commenters (11)

• Pharmaceutical Care Management Associationtrade assoc.

  2 filings · confidence 85%
• American Academy of Dermatology Associationtrade assoc.

  1 filing · confidence 85%
• American Intellectual Property Law Associationtrade assoc.

  1 filing · confidence 85%
• American Pharmacists Association (APhA)trade assoc.

  1 filing · confidence 97%
• American Society of Clinical Oncologytrade assoc.

  1 filing · confidence 85%
• Biotechnology Information Institutetrade assoc.

  1 filing · confidence 85%
• Eli Lilly and Companyunverified attribution

  1 filing · confidence 70%
• Generic Pharmaceutical Associationtrade assoc.

  1 filing · confidence 85%
• Immune Deficiency Foundation (IDF) - Submission of Informationtrade assoc.

  1 filing · confidence 85%
• Janssen Research Development LLCunverified attribution

  1 filing · confidence 70%
• National Patient Advocate Foundationtrade assoc.

  1 filing · confidence 85%